Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to direct the Joint Committee on Vaccination Immunisation to meet to discuss the recommendations of NHS England’s Palivizumab National Expert Group, in the context of an increase in RSV infections in the under-5 group; and if he will make a statement.

Following a letter from clinicians, the Joint Committee on Vaccination and Immunisation (JCVI) requested that the Palivizumab National Expert Group consider the eligibility of a sub-group of children with spinal muscular atrophy to receive a palivizumab vaccination. The Palivizumab National Expert Group has made its recommendations to the JCVI, which will be discussed in a forthcoming meeting.